A health industry researcher says pharmaceutical sales growth worldwide will slow this year due to expiring patents for blockbuster drugs and tighter price controls imposed by European governments. Health industry data firm IMS Health expects global prescription drug sales growth to slow to between 4 and 6 percent compared with...
more »